Zydus Lifesciences Limited has informed the Exchange regarding a press release dated January 19, 2024, titled "Zydus and Synthonenter into an exclusive licensing and supply agreement for Palbociclib Tablets (genericversion of IBRANCE��) for the US market".
Zydus Lifesciences Limited Press Release Jan 19 2024
Filed with NSE · · 3 pages · English
Release
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Jan 17 2024
- Press Release Dec 22 2023
- Press Release Dec 16 2023
- Press Release Dec 15 2023
- Press Release Dec 14 2023
Later from Zydus Lifesciences
- Press Release Jan 25 2024
- Zydus Lifesciences Limited Press Release Jan 30 2024
- Press Release Feb 08 2024
- Press Release Feb 09 2024
- Press Release Feb 16 2024
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences